利塞膦酸钠片致过敏性休克1例分析

doi:10.19803/j.1672-8629.2022.07.23

摘要/Abstract

摘要： 目的提醒在临床使用利塞膦酸钠片时应注意用药安全。方法通过分析2020年3月发生的1例由利塞膦酸钠片导致的过敏性休克病例及文献回顾利塞膦酸钠片常见的不良反应和致过敏性休克的发病机制。结果根据患者的临床表现及药物与用药时间的关联性,考虑利塞膦酸钠片导致过敏性休克可能性大,患者经积极抗过敏治疗及对症支持治疗后,过敏性休克症状得到缓解。结论对有药物过敏史的患者,临床开具患者初次使用口服药物时应慎重。

关键词: 利塞膦酸钠片, 口服制剂, 过敏性休克

Abstract: Objective To alert clinicians to adverse drug reactions induced by risedronate sodium tablets. Methods The clinical data of one case of anaphylactic shock caused by risedronate sodium tablets in March 2020 was analyzed while literature related to the common adverse reactions and pathogenesis of anaphylactic shock caused by risedronate sodium tablets was reviewed. Results Based on the patient's clinical manifestations and the correlations between the drug and the time of medication, it was suspected that risedronate sodium tablets might have caused anaphylactic shock. The patient's symptoms were relieved after active anti-allergic treatment and symptomatic treatment. Conclusion For patients with a history of drug allergy, oral drugs prescribed for the first time should be selected with caution.

Key words: risedronate sodium tablets, oral preparations, anaphylactic shock

中图分类号:

R994.11

杨莲娣. 利塞膦酸钠片致过敏性休克1例分析[J]. 中国药物警戒, 2022, 19(7): 795-798.

YANG Liandi. One case of anaphylactic shock caused by risedronate sodium tablets[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 795-798.

参考文献

[1] YU BL, LI YK, The adverse effects of bisphosphonates application[J].Chinese Journal of Osteoporosis(中国骨质疏松杂志), 2011, 17(1): 80-85.
[2] ZHOU JW, MA X, ZHAI SD.Evaluation of comparative effectiveness and safety of bisphosphonates[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2015, 31(12): 1197-1201.
[3] HUANG C, WANG SY, WENG XS.Progress in clinical application of bisphosphonates[J]. Journal of Practical Orthopaedics(实用骨科杂志), 2016, 22(1): 39-42.
[4] ZHOU R, YUAN Z, LIU J, et al.A randomized double-blind placebo-control clinical study of risedronate sodium in prevention or treatment for postmenopausal osteoporosis[J]. Chinese Journal of Osteoporosis(中国骨质疏松杂志), 2010, 16(3): 173-176.
[5] YANG X, WU YY, ZHANG SF, et al.Randomized, double-blind, multicenter comparative clinical trial of risedronate on bone mineral density in Chinese postmenopausal women[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2008, 24(3): 199-203.
[6] XIAO Y, LIU P, JIANG LF.A case of drug-induced shock caused by risedronate sodium[J]. Herald of Medicine(医药导报), 2015, 34(z1): 189.
[7] HU XL, LIU R, WANG YU.et al.Exfoliative dermatitis caused by risedronate sodium[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2012, 14(5): 304-305.
[8] BIANCHI L, HANSEL K, ROMITA P, et al.Erythema multiforme-like eruption induced by risedronate.[J]. Contact Dermatitis, 2017, 77(5): 348-349.
[9] YOUNG JK, SANG WK, JAE HL, et al.Marked elevation of procalc-itonin level can lead to a misdiagnosis of anaphylactic shock as septic shock[J]. International Journal of Infectious Diseases, 2015, 37: 93-94.
[10] BELHADJALI H, SLIM R, AOUAM K, et al.Cutaneous vasculitis induced by risedronate[J]. Allergy, 2008, 63(10): 1405.
[11] WANG ZJ, ZHAO WH, XIAN RL, et al.A case of anaphylactic shock caused by ibuprofen[J]. People's Military Surgeon(人民军医), 2014, 57(9): 1014.
[12] ZHOU GM.A case of anaphylactic shock caused by ibuprofen sustained-release capsules[J]. Journal of Chinese Physician(中国医师杂志), 2015, 17(S1): 210-210.
[13] PALM NW, ROSENSTEIN RK, MEDZHITOV R.Allergic host defences[J]. Nature, 2012, 484(7395): 465-472.
[14] CHEN M, LI W, WANG X, et al.Progress in research of the mechanism and preclinical evaluation of drug pseudoallergy[J].Chinese Journal of New Drugs(中国新药杂志), 2017, 26(1): 51-59.
[15] NISHIKAWA H, KITANI S.Gangliosides inhibit bee venommelittin cytotoxicity but not phospholipase A2-induceddegranulation in mast cells[J]. Toxicol Appl Pharmacol, 2011, 252(3): 228-236.
[16] WANG L,GONG GM, SU H.Research on mechanisms and evaluation models of traditional Chinese medicine-induced pseudo-allergy[J]. Drug Evaluation Research(药物评价研究), 2019, 42(12): 2471-2477.
[17] GANG HL, LIU Y, XIE SX, et al.Mechanism and evaluation methods of Chinese medicine injection induced allergic hypersensitivity reactions and pseudoallergic reactions[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2018, 38(4): 508-512.
[18] YANG YF, XIE JJ, CHEN M, et al.Research progress on allergic reaction mechanism of Chinese medicine injection[J]. Chinese Traditional Patent Medicine(中成药), 2019, 41(8): 1935-1940.
[19] YANG L, LIU GH.Pathogenesis, in vivo and in vitro test of drug allergy[J]. Chinese Journal of Allergy and Clinical Immunology(中华临床免疫和变态反应杂志), 2012, 6(2): 152-157.
[20] TANG ZF, MEI QX, YANG GY, et al.Discussion on main types of adverse drug reactions and treatment methods of traditional chinese medicine injections[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2019, 19(8): 1013-1016, 1020.
[21] LI XT, ZHAI SD, WANG Q, et al.Recommendations in guideline for emergency management of anaphylaxis[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2019(2): 85-91.
[22] MURARO A, ROBERTS G, WORM M, et al.Anaphylaxis: guidelines from the european academy of allergy and clinical immunology[J]. Allergy, 2014, 69(8): 1206-1245.
[23] PAOLA LM, ALESSANDRO A, ANNA D, et al.Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs[J]. Allergologia et Immunopathologia, 2015, 43(2): 1-4.